Vimentin filament controls integrin alpha 5 beta 1-mediated cell adhesion by binding to integrin through its Ser38 residue
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jiyoon | - |
dc.contributor.author | Jang, Jungim | - |
dc.contributor.author | Yang, Chansik | - |
dc.contributor.author | Kim, Eun Jin | - |
dc.contributor.author | Jung, Hosung | - |
dc.contributor.author | Kim, Chungho | - |
dc.date.accessioned | 2021-09-03T19:29:27Z | - |
dc.date.available | 2021-09-03T19:29:27Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2016-10 | - |
dc.identifier.issn | 0014-5793 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/87381 | - |
dc.description.abstract | Regulation of integrin affinity for its ligand is essential for cell adhesion and migration. Here, we found that direct interaction of vimentin with integrin beta 1 can enhance binding of integrin alpha 5 beta 1 to its ligand, fibronectin. Conversely, blocking the interaction reduced fibronectin binding, cell migration on a fibronectin-coated surface, and neural tube closure during Xenopus embryogenesis. We also found that withaferin A (WFA), a natural compound known to inhibit vimentin function, can suppress the vimentin-integrin interaction and abolish fibronectin binding. Finally, we identified Ser38 of vimentin as a critical residue for integrin binding. Our results suggest that phosphorylation of vimentin at Ser38 may regulate the integrin-ligand interaction, thus providing a molecular basis for antivimentin therapeutic strategies. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY-BLACKWELL | - |
dc.subject | TRANSMEMBRANE DOMAIN | - |
dc.subject | ACTIVATION | - |
dc.subject | PROTEIN | - |
dc.subject | TALIN | - |
dc.subject | ALPHA-IIB-BETA-3 | - |
dc.subject | EXPRESSION | - |
dc.subject | RECEPTOR | - |
dc.subject | KINDLIN | - |
dc.title | Vimentin filament controls integrin alpha 5 beta 1-mediated cell adhesion by binding to integrin through its Ser38 residue | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Chungho | - |
dc.identifier.doi | 10.1002/1873-3468.12430 | - |
dc.identifier.scopusid | 2-s2.0-84990224522 | - |
dc.identifier.wosid | 000386870000007 | - |
dc.identifier.bibliographicCitation | FEBS LETTERS, v.590, no.20, pp.3517 - 3525 | - |
dc.relation.isPartOf | FEBS LETTERS | - |
dc.citation.title | FEBS LETTERS | - |
dc.citation.volume | 590 | - |
dc.citation.number | 20 | - |
dc.citation.startPage | 3517 | - |
dc.citation.endPage | 3525 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Biophysics | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biophysics | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | TRANSMEMBRANE DOMAIN | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.subject.keywordPlus | TALIN | - |
dc.subject.keywordPlus | ALPHA-IIB-BETA-3 | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordPlus | KINDLIN | - |
dc.subject.keywordAuthor | cell adhesion | - |
dc.subject.keywordAuthor | integrin | - |
dc.subject.keywordAuthor | migration | - |
dc.subject.keywordAuthor | vimentin | - |
dc.subject.keywordAuthor | withaferin A | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.